No one ever dreams about their life-saving medicine being out of stock. What do you do when that happens?
Patients with cancer face waiting over a year for lifesaving medication that costs just $10 - as US drug shortages hit record high
The Daily Mail and Alexa Lardieri covered the impact drug shortages are having on US patients and highlighted the Change Maker Movement.
Mom Advocates for End to Drug shortage After Struggling to Find Medication for Daughter Diagnosed with Cancer
"This is a patient problem," said Bray. "This is a national problem. This is a global problem. The supply chain is very brittle. It breaks every day and there is no extra. And then what happens is, patients are prioritized, and some people get it and some people don't. And it's not always clear why."
Washington Grappling with Fixes to America’s Shortages of Vital Drugs
Angels for Change makes CNN's top Health Stories of 2023
What Will It Take for the US to Solve Drug Shortages?
Thank you Bloomberg and Riley Ray Griffin for discussing the US drug shortage crisis and interviewing our Chief Change Maker, Laura Bray.
“It is indescribably cruel to be faced with a shortage of a lifesaving drug,” Bray says. “How do you dangle a treatment before a child and then tell them they’re not important enough?” said Laura Bray.
To read the full article click here
Donate now to help us end drug shortages click here
#endingdrugshortagestogether
#nopatientleftbehind
America Is Having Yet Another Drug Shortage. Here's Why It Keeps Happening.
Thank you The New York Times and Emily Tucker for bringing awareness to America's drug shortage crisis and highlighting the work Angels for Change is doing to help patients in dire need. We look forward to continuing to partner with Emily and Marta Wosinska in 2024 as work to bring transparency and quantify some of the missing pieces in the race to end drug shortages.
Cancer Drug Shortages Won’t Get Better Under Biden’s Latest Plan
WASHINGTON — President Biden’s new plan to curb drug shortages by boosting domestic drug production won’t expand the supply of the chemotherapies that are currently in shortage, an administration official confirmed. The limited scope surprised experts, who told STAT Biden could have included those drugs in the effort.